CTC were detected in all advanced NSCLC ALK-positive and ALK-negative patients using NanoVelcro, meanwhile in 19 of 21 (90.49%) advanced NSCLC ALK-positive patients and 18 of 20 (90%) negative patients by CellSearch (Tables 1, 2). Here, ALK is linked to non-small cell lung carcinoma.